PricingLoginTell your story
Vol. II — No. 184Remarkable People · Exceptional CompaniesToday's Edition

antibody

(2)
AllCompaniesPeopleStoriesProducts
Company
Calluna Pharma
Health · Ai · Enterprise

Calluna Pharma

Calluna Pharma is an Oslo-based clinical-stage biotech building first-in-class antibodies that switch off the upstream signals driving inflammation and fibrosis. Formed in 2024 from the merger of Oxitope Pharma and Arxx Therapeutics and backed by a EUR 75 million Series A, the company targets damage-associated molecular patterns (DAMPs) such as S100A4 to halt diseases like idiopathic pulmonary fibrosis at their root rather than managing symptoms.

biotech · fibrosisRead →
Company
NGM Biopharmaceuticals
Health

NGM Biopharmaceuticals

NGM Biopharmaceuticals is a private South San Francisco biotech translating biology into first-in-class medicines, anchored by its GDF15/GFRAL antagonist NGM120 in Phase 2 trials for cancer cachexia and hyperemesis gravidarum.

biotech · biopharmaceuticalRead →